Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EBIT Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -14.6481.56139.20-22.3865.42

What is the latest EBIT Growth ratio of NEULAND LABORATORIES ?

The latest EBIT Growth ratio of NEULAND LABORATORIES is -14.64 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-14.64
Mar202481.56
Mar2023139.20
Mar2022-22.38
Mar202165.42

How is EBIT Growth of NEULAND LABORATORIES Trending?

Years EBIT Growth % Change
Mar2025 -14.64
Negative
Mar2024 81.56
-41.41
Mar2023 139.2
Positive
Mar2022 -22.38
Negative
Mar2021 65.42 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EBIT Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,149.9 Cr -3.7% -4.4% 24.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.1% 6.2% 13.5% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1% 3.3% 14.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,928.0 Cr -0% 10% 45.6% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr -0.6% 3.3% 16.4% Stock Analytics
CIPLA ₹107,043.0 Cr -2% -0.6% -6.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-3.7%

-4.4%

24.3%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses